ArticleThe Lancet regional health. Europe2026
War-related displacement, conflict intensity, and treatment delivery factors in opioid agonist maintenance treatment discontinuation following Russia's invasion of Ukraine: a national cohort study.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Background: Ukraine has Europe's second-largest HIV epidemic, driven mainly by injection opioid use. Opioid agonist maintenance treatment (OAMT) is the most effective treatment for opioid use disorder (OUD) and a key HIV prevention strategy. Following Russia's invasion of Ukraine on 24 February 2022, continuity of OAMT was threatened. We examined the effects of displacement, war exposure, and treatment delivery factors on OAMT discontinuation during the first two years of the expanded war. Methods: In this retrospective analysis of a prospective national cohort study, we used individual-level data from Ukraine's national OAMT registry. Adults (≥18 years) with diagnosed OUD receiving OAMT in 252 government-operated clinics as of 23 February 2022 were followed through 1 January 2024. The primary outcome was treatment discontinuation. War exposure was classified using k-means clustering of six standardised regional indicators: air raids, explosions, artillery attacks, internal displacement, occupation days, and frontline days. Regions were categorised as low-intensity, high-intensity, or frontline. Displacement was modelled as a time-dependent variable in frailty-adjusted extended Cox proportional hazards models. Findings: In total, 17,211 participants were included (14,554/17,211 (84.6%) men; mean age 38.9 years, with standard deviation = 7.2). During follow-up, 5040/17,211 (29.3%) discontinued OAMT and 921/17,211 (5.4%) died. Compared with local patients in low-intensity regions, discontinuation risk was higher in high-intensity (aHR 1.74; 95% CI 1.40-2.15) and frontline regions (aHR 3.09; 95% CI 2.80-3.42). Internally displaced persons faced markedly elevated risk in low-intensity (aHR 3.55; 95% CI 2.92-4.32), high-intensity (aHR 5.90; 95% CI 4.52-7.69), and frontline regions (aHR 8.26; 95% CI 5.43-12.56). Optimal dosing (aHR 0.74; 95% CI 0.69-0.78) and unsupervised dosing (aHR 0.71; 95% CI 0.64-0.78) were protective. Females had higher discontinuation risk (aHR 1.20; 95% CI 1.11-1.30) than males. Interpretation: Displacement and residence in high-intensity war regions were dominant drivers of OAMT discontinuation. Flexible dosing policies and continuity strategies for displaced patients are essential to sustain OAMT during war. Funding: National Institute on Drug Abuse (R01DA033679, R01DA043125, R01DA045384, F31DA054861, R01DA054703).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.